Validation of Antibody Specificity: Recommendations from the IWGAV and the Path Forward

Research antibodies are critical for innovation and discovery, but the use of poorly characterized reagents can negatively impact the rigor and reproducibility of biomedical science. A new proposal published September 5 in Nature Methods shows the way to better research tools. In this blog, Dr. Uhlén, Professor of Microbiology at Royal Institute of Technology, a noted protein biochemist,  founder of the Human Protein Atlas, and Chair of the International Working Group on Antibody Validation (IWGAV) discusses strategies of the IWGAV.